"World's Most Complete Market Research Reports Repository"

Global Prostate Cancer Medicine Market Size, Status and Forecast 2018-2025

This report focuses on the global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Medicine development in United States, Europe and China.

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.
In 2017, the global Prostate Cancer Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG

Market segment by Type, the product can be split into
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy

Market segment by Application, split into
Hospitals
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players.
To present the Prostate Cancer Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prostate Cancer Medicine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type (2013-2025)
1.4.2 LHRH Antagonists
1.4.3 LHRH Analogs
1.4.4 Antiandrogens
1.4.5 Pipeline Drugs for Hormonal Therapy
1.5 Market by Application
1.5.1 Global Prostate Cancer Medicine Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prostate Cancer Medicine Market Size
2.2 Prostate Cancer Medicine Growth Trends by Regions
2.2.1 Prostate Cancer Medicine Market Size by Regions (2013-2025)
2.2.2 Prostate Cancer Medicine Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Prostate Cancer Medicine Market Size by Manufacturers
3.1.1 Global Prostate Cancer Medicine Revenue by Manufacturers (2013-2018)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Prostate Cancer Medicine Key Players Head office and Area Served
3.3 Key Players Prostate Cancer Medicine Product/Solution/Service
3.4 Date of Enter into Prostate Cancer Medicine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prostate Cancer Medicine Market Size by Type (2013-2018)
4.2 Global Prostate Cancer Medicine Market Size by Application (2013-2018)

5 United States
5.1 United States Prostate Cancer Medicine Market Size (2013-2018)
5.2 Prostate Cancer Medicine Key Players in United States
5.3 United States Prostate Cancer Medicine Market Size by Type
5.4 United States Prostate Cancer Medicine Market Size by Application

6 Europe
6.1 Europe Prostate Cancer Medicine Market Size (2013-2018)
6.2 Prostate Cancer Medicine Key Players in Europe
6.3 Europe Prostate Cancer Medicine Market Size by Type
6.4 Europe Prostate Cancer Medicine Market Size by Application

7 China
7.1 China Prostate Cancer Medicine Market Size (2013-2018)
7.2 Prostate Cancer Medicine Key Players in China
7.3 China Prostate Cancer Medicine Market Size by Type
7.4 China Prostate Cancer Medicine Market Size by Application

8 Japan
8.1 Japan Prostate Cancer Medicine Market Size (2013-2018)
8.2 Prostate Cancer Medicine Key Players in Japan
8.3 Japan Prostate Cancer Medicine Market Size by Type
8.4 Japan Prostate Cancer Medicine Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prostate Cancer Medicine Market Size (2013-2018)
9.2 Prostate Cancer Medicine Key Players in Southeast Asia
9.3 Southeast Asia Prostate Cancer Medicine Market Size by Type
9.4 Southeast Asia Prostate Cancer Medicine Market Size by Application

10 India
10.1 India Prostate Cancer Medicine Market Size (2013-2018)
10.2 Prostate Cancer Medicine Key Players in India
10.3 India Prostate Cancer Medicine Market Size by Type
10.4 India Prostate Cancer Medicine Market Size by Application

11 Central & South America
11.1 Central & South America Prostate Cancer Medicine Market Size (2013-2018)
11.2 Prostate Cancer Medicine Key Players in Central & South America
11.3 Central & South America Prostate Cancer Medicine Market Size by Type
11.4 Central & South America Prostate Cancer Medicine Market Size by Application

12 International Players Profiles
12.1 AstraZeneca plc
12.1.1 AstraZeneca plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostate Cancer Medicine Introduction
12.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2013-2018)
12.1.5 AstraZeneca plc Recent Development
12.2 Active Biotech
12.2.1 Active Biotech Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostate Cancer Medicine Introduction
12.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2013-2018)
12.2.5 Active Biotech Recent Development
12.3 Bristol Myers-Squibb
12.3.1 Bristol Myers-Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostate Cancer Medicine Introduction
12.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2013-2018)
12.3.5 Bristol Myers-Squibb Recent Development
12.4 Teva Pharmaceuticals Industries Ltd.
12.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostate Cancer Medicine Introduction
12.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2013-2018)
12.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prostate Cancer Medicine Introduction
12.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2013-2018)
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer Inc.
12.6.1 Pfizer Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prostate Cancer Medicine Introduction
12.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2013-2018)
12.6.5 Pfizer Inc. Recent Development
12.7 Bayer AG
12.7.1 Bayer AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prostate Cancer Medicine Introduction
12.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2013-2018)
12.7.5 Bayer AG Recent Development
12.8 Abbott Laboratories
12.8.1 Abbott Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prostate Cancer Medicine Introduction
12.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2013-2018)
12.8.5 Abbott Laboratories Recent Development
12.9 Astellas Pharma Inc.
12.9.1 Astellas Pharma Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prostate Cancer Medicine Introduction
12.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2013-2018)
12.9.5 Astellas Pharma Inc. Recent Development
12.10 Roche Holding AG
12.10.1 Roche Holding AG Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prostate Cancer Medicine Introduction
12.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2013-2018)
12.10.5 Roche Holding AG Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Prostate Cancer Medicine Key Market Segments
Table Key Players Prostate Cancer Medicine Covered
Table Global Prostate Cancer Medicine Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Prostate Cancer Medicine Market Size Market Share by Type 2013-2025
Figure LHRH Antagonists Figures
Table Key Players of LHRH Antagonists
Figure LHRH Analogs Figures
Table Key Players of LHRH Analogs
Figure Antiandrogens Figures
Table Key Players of Antiandrogens
Figure Pipeline Drugs for Hormonal Therapy Figures
Table Key Players of Pipeline Drugs for Hormonal Therapy
Table Global Prostate Cancer Medicine Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Other Case Studies
Figure Prostate Cancer Medicine Report Years Considered
Table Global Prostate Cancer Medicine Market Size 2013-2025 (Million US$)
Figure Global Prostate Cancer Medicine Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Prostate Cancer Medicine Market Size by Regions 2013-2025 (Million US$)
Table Global Prostate Cancer Medicine Market Size by Regions 2013-2018 (Million US$)
Table Global Prostate Cancer Medicine Market Share by Regions 2013-2018
Figure Global Prostate Cancer Medicine Market Share by Regions 2013-2018
Figure Global Prostate Cancer Medicine Market Share by Regions 2018
Table Market Top Trends
Table Global Prostate Cancer Medicine Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Prostate Cancer Medicine Market Share by Manufacturers (2013-2018)
Figure Global Prostate Cancer Medicine Market Share by Manufacturers in 2018
Table Global Prostate Cancer Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prostate Cancer Medicine Product/Solution/Service
Table Date of Enter into Prostate Cancer Medicine Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table Global Prostate Cancer Medicine Market Size Share by Type (2013-2018)
Figure Global Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
Table Global Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table Global Prostate Cancer Medicine Market Size Share by Application (2013-2018)
Figure Global Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
Figure Global Prostate Cancer Medicine Revenue Market Share by Application in 2017
Figure United States Prostate Cancer Medicine Market Size 2013-2018 (Million US$)
Table United States Key Players Prostate Cancer Medicine Revenue (2017-2018) (Million US$)
Table United States Key Players Prostate Cancer Medicine Market Share (2017-2018)
Table United States Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table United States Prostate Cancer Medicine Market Share by Type (2013-2018)
Table United States Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table United States Prostate Cancer Medicine Market Share by Application (2013-2018)
Figure Europe Prostate Cancer Medicine Market Size 2013-2018 (Million US$)
Table Europe Key Players Prostate Cancer Medicine Revenue (2017-2018) (Million US$)
Table Europe Key Players Prostate Cancer Medicine Market Share (2017-2018)
Table Europe Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table Europe Prostate Cancer Medicine Market Share by Type (2013-2018)
Table Europe Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table Europe Prostate Cancer Medicine Market Share by Application (2013-2018)
Figure China Prostate Cancer Medicine Market Size 2013-2018 (Million US$)
Table China Key Players Prostate Cancer Medicine Revenue (2017-2018) (Million US$)
Table China Key Players Prostate Cancer Medicine Market Share (2017-2018)
Table China Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table China Prostate Cancer Medicine Market Share by Type (2013-2018)
Table China Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table China Prostate Cancer Medicine Market Share by Application (2013-2018)
Figure Japan Prostate Cancer Medicine Market Size 2013-2018 (Million US$)
Table Japan Key Players Prostate Cancer Medicine Revenue (2017-2018) (Million US$)
Table Japan Key Players Prostate Cancer Medicine Market Share (2017-2018)
Table Japan Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table Japan Prostate Cancer Medicine Market Share by Type (2013-2018)
Table Japan Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table Japan Prostate Cancer Medicine Market Share by Application (2013-2018)
Figure Southeast Asia Prostate Cancer Medicine Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Prostate Cancer Medicine Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Prostate Cancer Medicine Market Share (2017-2018)
Table Southeast Asia Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Prostate Cancer Medicine Market Share by Type (2013-2018)
Table Southeast Asia Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Prostate Cancer Medicine Market Share by Application (2013-2018)
Figure India Prostate Cancer Medicine Market Size 2013-2018 (Million US$)
Table India Key Players Prostate Cancer Medicine Revenue (2017-2018) (Million US$)
Table India Key Players Prostate Cancer Medicine Market Share (2017-2018)
Table India Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table India Prostate Cancer Medicine Market Share by Type (2013-2018)
Table India Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table India Prostate Cancer Medicine Market Share by Application (2013-2018)
Figure Central & South America Prostate Cancer Medicine Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Prostate Cancer Medicine Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Prostate Cancer Medicine Market Share (2017-2018)
Table Central & South America Prostate Cancer Medicine Market Size by Type (2013-2018) (Million US$)
Table Central & South America Prostate Cancer Medicine Market Share by Type (2013-2018)
Table Central & South America Prostate Cancer Medicine Market Size by Application (2013-2018) (Million US$)
Table Central & South America Prostate Cancer Medicine Market Share by Application (2013-2018)
Table AstraZeneca plc Company Details
Table AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2013-2018) (Million US$)
Figure AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table AstraZeneca plc Recent Development
Table Active Biotech Company Details
Table Active Biotech Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Active Biotech Recent Development
Table Bristol Myers-Squibb Company Details
Table Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Bristol Myers-Squibb Recent Development
Table Teva Pharmaceuticals Industries Ltd. Company Details
Table Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Teva Pharmaceuticals Industries Ltd. Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Johnson & Johnson Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Pfizer Inc. Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Bayer AG Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Abbott Laboratories Recent Development
Table Astellas Pharma Inc. Company Details
Table Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Astellas Pharma Inc. Recent Development
Table Roche Holding AG Company Details
Table Roche Holding AG Revenue in Prostate Cancer Medicine Business (2013-2018)(Million US$)
Figure Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2013-2018)
Table Roche Holding AG Recent Development
Table Global Prostate Cancer Medicine Market Size by Regions (Million US$) 2018-2025
Figure Global Prostate Cancer Medicine Market Size Share by Regions (2018-2025)
Figure Global Prostate Cancer Medicine Market Size Share by Regions in 2025
Figure United States Prostate Cancer Medicine Market Size Forecast (2018-2025)(Million USD)
Figure Europe Prostate Cancer Medicine Market Size Forecast (2018-2025)(Million USD)
Figure China Prostate Cancer Medicine Market Size Forecast (2018-2025)(Million USD)
Figure Japan Prostate Cancer Medicine Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Prostate Cancer Medicine Market Size Forecast (2018-2025)(Million USD)
Figure India Prostate Cancer Medicine Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Prostate Cancer Medicine Market Size Forecast (2018-2025)(Million USD)
Table Global Prostate Cancer Medicine Market Size by Product (2018-2025) (Million US$)
Figure Global Prostate Cancer Medicine Market Size by Product (2018-2025)
Figure Global Prostate Cancer Medicine Market Size by Product in 2025
Table Global Prostate Cancer Medicine Market Size by Application (2018-2025) (Million US$)
Figure Global Prostate Cancer Medicine Market Size by Application (2018-2025)
Figure Global Prostate Cancer Medicine Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type